Literature DB >> 26253815

Longevity of implantable cardioverter-defibrillators in a single-center population.

Joachim Seegers1,2, Pascal Muñoz Expósito1, Lars Lüthje1, Thomas Fischer1, Matthias Lueken1, Hannes Wenk1, Samuel T Sossalla1, Gerd Hasenfuss1, Markus Zabel3.   

Abstract

BACKGROUND OR
PURPOSE: Real-life comparative data of implantable cardioverter-defibrillator (ICD) longevity are needed to identify the best possible device longevity for optimal patient comfort and to minimize risk for multiple replacements.
METHODS: We retrospectively studied ICD longevity in a large single-center population. At our institution, 1272 consecutive patients were implanted with 1665 ICD or cardiac resynchronization therapy with defibrillator (CRT-D) devices between 1998 and 2010. Device data and follow-up were retrieved from the continuous ICD clinic documentation, and generator replacements were verified from the hospital charts. Kaplan-Meier event probabilities for the time to generator replacement were calculated according to device type, pacing percentage (sum of atrial, right and left ventricular pacing, if applicable) and right ventricular pacing threshold, incidence of ICD shocks, and manufacturer. Multivariate Cox proportional hazards regression was performed in addition.
RESULTS: A total of 470 devices were replaced for elective replacement indicator. These occurred after 5.4 years (95% confidence interval, 5.1 to 5.6 years) in 175 of 625 implanted Boston Scientific or Guidant devices, after 5.7 years (5.5 to 5.9 years) in 266 of 883 Medtronic devices, and 5.2 years (5.0 to 5.4 years) in 29 of 157 Biotronik devices, respectively. Differences between manufacturers remained significant upon multivariate analysis (Medtronic vs. Boston Scientific: P = 0.01; both vs. Biotronik: P < 0.01) as did differences of device type (single- and dual-chamber ICD vs. CRT-D, P < 0.01) and pacing percentage (P < 0.01). Pacing output and ICD shocks did not influence battery longevity.
CONCLUSION: ICD longevity differed significantly between manufacturers, independent of device type or pacing parameters.

Entities:  

Keywords:  Battery; Implantable cardioverter-defibrillator; Longevity

Mesh:

Year:  2015        PMID: 26253815     DOI: 10.1007/s10840-015-0044-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  24 in total

1.  Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.

Authors:  C Jan Willem Borleffs; Joep Thijssen; Mihály K de Bie; Johannes B van Rees; Guido H van Welsenes; Lieselot van Erven; Jeroen J Bax; Suzanne C Cannegieter; Martin J Schalij
Journal:  Pacing Clin Electrophysiol       Date:  2010-04-27       Impact factor: 1.976

2.  Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.

Authors:  Joep Thijssen; C Jan Willem Borleffs; Johannes B van Rees; SumChe Man; Mihály K de Bie; Jeroen Venlet; Enno T van der Velde; Lieselot van Erven; Martin J Schalij
Journal:  Heart Rhythm       Date:  2011-11-15       Impact factor: 6.343

3.  Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life.

Authors:  Guido H Van Welsenes; Johannes B Van Rees; Joep Thijssen; Serge A Trines; Lieselot Van Erven; Martin J Schalij; C J W Borleffs
Journal:  J Cardiovasc Electrophysiol       Date:  2011-07-21

4.  ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

Authors:  G Gregoratos; M D Cheitlin; A Conill; A E Epstein; C Fellows; T B Ferguson; R A Freedman; M A Hlatky; G V Naccarelli; S Saksena; R C Schlant; M J Silka
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs).

Authors:  Tali Shafat; Yael Baumfeld; Victor Novack; Yuval Konstantino; Guy Amit
Journal:  Clin Res Cardiol       Date:  2012-07-14       Impact factor: 5.460

7.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

8.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

9.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

10.  Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.

Authors:  Giuseppe Boriani; Frieder Braunschweig; Jean Claude Deharo; Francisco Leyva; Andrzej Lubinski; Carlo Lazzaro
Journal:  Europace       Date:  2013-05-21       Impact factor: 5.214

View more
  2 in total

1.  "Real life" longevity of implantable cardioverter-defibrillator devices.

Authors:  Antonis S Manolis; Themistoklis Maounis; Spyridon Koulouris; Vassilios Vassilikos
Journal:  Clin Cardiol       Date:  2017-05-22       Impact factor: 2.882

2.  Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.

Authors:  Stefano Poli; Giuseppe Boriani; Massimo Zecchin; Domenico Facchin; Maurizio Gasparini; Maurizio Landolina; Renato Pietro Ricci; Corrado Lanera; Dario Gregori; Alessandro Proclemer
Journal:  J Am Heart Assoc       Date:  2019-07-25       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.